Skip to main content

STIFEL FINANCIAL CORP

Position in VKTX — Viking Therapeutics, Inc.

CIK 720672 ST. LOUIS, MO

Position in VKTX

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$11,080,553
-$768,773 QoQ
Shares Held
340,521
+1.1% QoQ
Ownership
0.293%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 94.1404494876968.ToString("F0")% Shared 0.ToString("F0")% None 5.859550512303207.ToString("F0")%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

STIFEL FINANCIAL CORP holds $433,142,280 across 103 Biotechnology names. VKTX ranks #11 (2.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VKTX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $11,080,553 340,521
2025-12-31 $11,849,326 336,820
2025-09-30 $9,207,644 350,367
2025-06-30 $9,975,871 376,448
2025-03-31 $8,535,816 353,450
2024-12-31 $7,195,674 178,819
2024-09-30 $8,315,640 131,348
2024-06-30 $3,625,459 68,392
2024-03-31 $1,958,242 23,881
2023-12-31 $190,510 10,237
2021-09-30 $130,410 20,766
2021-06-30 $124,987 20,866
2021-03-31 $191,698 30,308
2020-12-31 $110,528 19,632
2020-09-30 $118,809 20,414
2020-06-30 $142,217 19,725
2020-03-31 $97,657 20,867